Filing Flows › Amgen (AMGN) › Q2 2026
Amgen (AMGN) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 5, 2026
Amgen (AMGN) reported revenue of $10.1B for the second quarter 2026 (Q2 2026), +10% from a year earlier and +17% from the quarter before. Operating margin was 35.0%, net earnings $2.4B (23.6% of revenue).
Amgen, Q2 2026: revenue $10.1B (+10% year over year), operating margin 35.0%, net earnings $2.4B, operating cash flow $4.0B. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.1B | +17% | +10% |
| Operating profit | $3.5B | +32% | +32% |
| Net earnings | $2.4B | +31% | +66% |
| Operating cash flow | $4.0B | +83% | +76% |
| Free cash flow | $3.5B | — | +86% |
What changed
Revenue was $10.1B in Q2 2026, up 10% year over year and up 17% from the previous quarter. Product sales was the largest line at 95% of revenue. Product sales added $0.77B year over year (up 9%), 88% of the total change.
Operating profit was $3.5B, a 35.0% margin (up 6.0 points year over year). Of the extra revenue versus Q2 2025, 98% reached operating profit, above the 29% margin then. Total costs grew 0% against revenue growth of 10%. The fastest-growing cost line was Other operating costs (+51%). Net earnings were $2.4B, up 66% year over year. The effective tax rate was 14.2%.
Operating cash flow was $4.0B (up 76% year over year), 169% of net earnings. Non-cash charges added back $1.1B of depreciation and amortization and $0.17B of share-based compensation. Working capital and other items added $0.35B. After capital Expenditures ($0.50B), free cash flow as the company reports it was $3.5B.
Questions
What was Amgen's revenue in the second quarter 2026?
Amgen (AMGN) reported revenue of $10.1B for the second quarter 2026 (Q2 2026), +10% from a year earlier and +17% from the quarter before.
Was Amgen profitable in the second quarter 2026?
Operating profit was $3.5B (35.0% of revenue) and net earnings $2.4B.
Source: Amgen 10-Q on SEC EDGAR.